SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Recent Accounting Pronouncements (Details) - USD ($)		3 Months Ended
		Mar. 31, 2018		Mar. 31, 2017	Dec. 31, 2017
Assets [Abstract]
Accounts receivable		$ 19,165,670	[1]		$ 4,655,105
Deferred royalty buy-down		1,648,319	[1]		1,794,126
Deferred royalty buy-down		1,600,000			2,500,000
Deferred tax assets, net		403,944	[1]		1,739,706
Liabilities [Abstract]
Accounts payable and accrued expenses		1,781,163	[1]		933,998
Deferred revenue		135,000			6,400,000
Deferred revenue		117,635	[1]		1,057,979
Income tax payable		2,535,676	[1]		68,733
Deferred revenue, long term		17,635	[1]		5,340,708
Equity [Abstract]
Retained earnings adjustment		56,102,054	[1]		41,939,115
Contract assets		7,000,000
Revenues [Abstract]
Total revenues		7,089,409	[1]	$ 7,690,619
Costs and expenses [Abstract]
General and administrative		2,069,633	[1]	2,425,717
Provision for income taxes		1,078,574	[1]	1,769,683
Net income		3,978,604	[1]	3,344,753
Endo [Member]
Assets [Abstract]
Accounts receivable		19,165,670			4,655,105
Deferred royalty buy-down					(2,500,000)
Deferred tax assets, net					1,739,706
Liabilities [Abstract]
Accounts payable and accrued expenses -third party royalties					(400,000)
Deferred revenue					(6,400,000)
Income tax payable					0
Equity [Abstract]
Retained earnings adjustment					(2,900,000)
Revenues [Abstract]
Total revenues		7,089,409		7,690,619
Royalties [Member]
Revenues [Abstract]
Total revenues		7,085,000	[1]	$ 7,686,210
ASU 2014-09 [Member] | Endo [Member]
Assets [Abstract]
Accounts receivable					12,300,000
Deferred royalty buy-down					(2,900,000)
Deferred tax assets, net					400,000
Liabilities [Abstract]
Accounts payable and accrued expenses -third party royalties					(900,000)
Deferred revenue					(100,000)
Income tax payable					(1,400,000)
Equity [Abstract]
Retained earnings adjustment					7,400,000
Adjustments / Effect of Change Higher / (Lower) [Member] | ASU 2014-09 [Member]
Assets [Abstract]
Accounts receivable		7,045,000
Deferred royalty buy-down		(366,279)
Deferred tax assets, net		(1,292,988)
Liabilities [Abstract]
Accounts payable and accrued expenses		510,000
Deferred revenue		(906,219)
Income tax payable		1,246,699
Deferred revenue, long term		(5,155,930)
Equity [Abstract]
Retained earnings adjustment		9,661,338
Costs and expenses [Abstract]
General and administrative		(17,418)
Provision for income taxes		(141,670)
Net income		(522,314)
Adjustments / Effect of Change Higher / (Lower) [Member] | ASU 2014-09 [Member] | Endo [Member]
Assets [Abstract]
Accounts receivable	[2]				7,600,000
Deferred royalty buy-down	[3]				(400,000)
Deferred tax assets, net	[4]				(1,300,000)
Liabilities [Abstract]
Accounts payable and accrued expenses -third party royalties	[3]				(500,000)
Deferred revenue	[5]				6,300,000
Income tax payable	[6]				(1,400,000)
Equity [Abstract]
Retained earnings adjustment					$ 10,300,000
Adjustments / Effect of Change Higher / (Lower) [Member] | ASU 2014-09 [Member] | Royalties [Member]
Revenues [Abstract]
Total revenues		(646,566)
Adjusted / Balances Without Adoption of New Revenue Standard [Member] | ASU 2014-09 [Member]
Assets [Abstract]
Accounts receivable		12,120,670
Deferred royalty buy-down		2,014,598
Deferred tax assets, net		1,696,932
Liabilities [Abstract]
Accounts payable and accrued expenses		1,271,163
Deferred revenue		1,023,854
Income tax payable		1,288,977
Deferred revenue, long term		5,173,564
Equity [Abstract]
Retained earnings adjustment		46,440,716
Costs and expenses [Abstract]
General and administrative		2,087,921
Provision for income taxes		1,220,244
Net income		4,500,918
Adjusted / Balances Without Adoption of New Revenue Standard [Member] | ASU 2014-09 [Member] | Royalties [Member]
Revenues [Abstract]
Total revenues		$ 7,731,566

[1] As of January 1, 2018, the Company adopted the requirements of ASC 606 using the modified retrospective adoption method, and as a result, there is a lack of comparability of certain amounts to the prior periods presented. See Note 2 for additional discussion.

[2] This adjustment represents the elimination of the one quarter lag by recognizing royalty revenues based on of XIALFLEX net sales and mark-up on cost of goods sold revenues reported to us by Endo for the fourth quarter of 2017.

[3] Represents the amortization of the royalty buy-down and third party royalties expense associated royalty revenues based on XIALFLEX net sales reported to us by Endo for the fourth quarter of 2017.

[4] To reverse a deferred tax asset associated with the deferred revenue balance of the prepaid mark-up on cost of goods sold by non-affiliated sublicensees of Endo outside of the U.S.

[5] Represents the remaining deferred revenue balance of the prepaid mark-up on cost of goods sold based on sales by non-affiliated sublicensees of Endo outside of the U.S.

[6] To create a tax liability associated the elimination of the one quarter lag by recognizing royalty revenues based on of XIALFLEX net sales and mark-up on cost of goods sold revenues reported to us by Endo for the fourth quarter of 2017.